Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Luteolin and abyssinone II as potential inhibitors of SARS-CoV-2: an in silico molecular modeling approach in battling the COVID-19 outbreak
Mohammad Mahfuz Ali Khan Shawan, Sajal Kumar Halder, Md. Ashraful Hasan
Bulletin of the National Research Centre/Bulletin of the National Research Center (2021) Vol. 45, Iss. 1
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Anti-Inflammatory and Active Biological Properties of the Plant-Derived Bioactive Compounds Luteolin and Luteolin 7-Glucoside
Sabrina Caporali, Alessandro De Stefano, Cinzia Calabrese, et al.
Nutrients (2022) Vol. 14, Iss. 6, pp. 1155-1155
Open Access | Times Cited: 142
Propolis, Bee Honey, and Their Components Protect against Coronavirus Disease 2019 (COVID-19): A Review of In Silico, In Vitro, and Clinical Studies
Amira Mohammed Ali, Hiroshi Kunugi
Molecules (2021) Vol. 26, Iss. 5, pp. 1232-1232
Open Access | Times Cited: 116
Promising Antiviral Activities of Natural Flavonoids against SARS-CoV-2 Targets: Systematic Review
Ridhima Kaul, Pradipta Paul, Sanjay Kumar, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11069-11069
Open Access | Times Cited: 76
Honeysuckle (Lonicera japonica) and Huangqi (Astragalus membranaceus) Suppress SARS-CoV-2 Entry and COVID-19 Related Cytokine Storm in Vitro
Yuan-Chieh Yeh, Ly Hien Doan, Zi-Yi Huang, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 59
Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2
Kaifu Gao, Rui Wang, Jiahui Chen, et al.
Chemical Reviews (2022) Vol. 122, Iss. 13, pp. 11287-11368
Open Access | Times Cited: 58
Advances in Computational and Bioinformatics Tools and Databases for Designing and Developing a Multi-Epitope-Based Peptide Vaccine
Mohammad Mahfuz Ali Khan Shawan, Ashish Ranjan Sharma, Sajal Kumar Halder, et al.
International Journal of Peptide Research and Therapeutics (2023) Vol. 29, Iss. 4
Open Access | Times Cited: 35
Flavonoids derived from medicinal plants as a COVID‐19 treatment
Mentor Sopjani, Francesca Falco, Federica Impellitteri, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 3, pp. 1589-1609
Open Access | Times Cited: 8
Flavonoids as potential phytotherapeutics to combat cytokine storm in SARS‐CoV‐2
Abhishek Gour, Diksha Manhas, Swarnendu Bag, et al.
Phytotherapy Research (2021) Vol. 35, Iss. 8, pp. 4258-4283
Open Access | Times Cited: 46
A Comprehensive Study to Unleash the Putative Inhibitors of Serotype2 of Dengue Virus: Insights from an In Silico Structure-Based Drug Discovery
Sajal Kumar Halder, Iqrar Ahmad, Jannatul Fardous Shathi, et al.
Molecular Biotechnology (2022) Vol. 66, Iss. 4, pp. 612-625
Open Access | Times Cited: 31
Cyanidin-3-O-glucoside and Peonidin-3-O-glucoside-Rich Fraction of Black Rice Germ and Bran Suppresses Inflammatory Responses from SARS-CoV-2 Spike Glycoprotein S1-Induction In Vitro in A549 Lung Cells and THP-1 Macrophages via Inhibition of the NLRP3 Inflammasome Pathway
Warathit Semmarath, Sariya Mapoung, Sonthaya Umsumarng, et al.
Nutrients (2022) Vol. 14, Iss. 13, pp. 2738-2738
Open Access | Times Cited: 25
In Silico Screening of Bioactive Compounds of Representative Seaweeds to Inhibit SARS-CoV-2 ACE2-Bound Omicron B.1.1.529 Spike Protein Trimer
Muruganantham Bharathi, Bhagavathi Sundaram Sivamaruthi, Periyanaina Kesika, et al.
Marine Drugs (2022) Vol. 20, Iss. 2, pp. 148-148
Open Access | Times Cited: 24
Does Oxidative Stress Management Help Alleviation of COVID-19 Symptoms in Patients Experiencing Diabetes?
Alok Kumar Paul, Md. Kamal Hossain, Tooba Mahboob, et al.
Nutrients (2022) Vol. 14, Iss. 2, pp. 321-321
Open Access | Times Cited: 23
Synergistic deciphering of bioenergy production and electron transport characteristics to screen traditional Chinese medicine (TCM) for COVID-19 drug development
Po‐Wei Tsai, Cheng-Yang Hsieh, Jasmine U. Ting, et al.
Journal of the Taiwan Institute of Chemical Engineers (2022) Vol. 135, pp. 104365-104365
Open Access | Times Cited: 23
QSAR, homology modeling, and docking simulation on SARS-CoV-2 and pseudomonas aeruginosa inhibitors, ADMET, and molecular dynamic simulations to find a possible oral lead candidate
Emmanuel Israel Edache, Adamu Uzairu, Paul Andrew Mamza, et al.
Journal of Genetic Engineering and Biotechnology (2022) Vol. 20, Iss. 1, pp. 88-88
Open Access | Times Cited: 23
Antiviral Potential of Plants against COVID-19 during Outbreaks—An Update
Qazi Mohammad Sajid Jamal
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13564-13564
Open Access | Times Cited: 22
Epicatechin is a promising novel inhibitor of SARS-CoV-2 entry by disrupting interactions between angiotensin-converting enzyme type 2 and the viral receptor binding domain: A computational/simulation study
Mohammed Baqur S. Al‐Shuhaib, Hayder O. Hashim, Jafar M. B. Al‐Shuhaib
Computers in Biology and Medicine (2021) Vol. 141, pp. 105155-105155
Open Access | Times Cited: 29
Protective effect of luteolin against chemical and natural toxicants by targeting NF‐κB pathway
Sina Mahdiani, Navid Omidkhoda, Shadi Heidari, et al.
BioFactors (2022) Vol. 48, Iss. 4, pp. 744-762
Closed Access | Times Cited: 20
Novel Drug Design for Treatment of COVID-19: A Systematic Review of Preclinical Studies
Sarah Mousavi, Shima Zare, Mahmoud Mirzaei, et al.
Canadian Journal of Infectious Diseases and Medical Microbiology (2022) Vol. 2022, pp. 1-70
Open Access | Times Cited: 18
In Silico Identification and Analysis of Potentially Bioactive Antiviral Phytochemicals against SARS‐CoV‐2: A Molecular Docking and Dynamics Simulation Approach
Sajal Kumar Halder, Ive Sultana, Md Nazmussakib Shuvo, et al.
BioMed Research International (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 11
The Antiviral Potential of Perilla frutescens: Advances and Perspectives
Jing Chen, Yi Zhao, Jie Cheng, et al.
Molecules (2024) Vol. 29, Iss. 14, pp. 3328-3328
Open Access | Times Cited: 3
SHP-1/STAT3 Interaction Is Related to Luteolin-Induced Myocardial Ischemia Protection
Donghai Liu, Hong Luo, Chenhui Qiao
Inflammation (2021) Vol. 45, Iss. 1, pp. 88-99
Open Access | Times Cited: 23
Natural and Semi-Synthetic Flavonoid Anti-SARS-CoV-2 Agents for the Treatment of Long COVID-19 Disease and Neurodegenerative Disorders of Cognitive Decline
James Melrose, Margaret M. Smith
Frontiers in Bioscience-Elite (2022) Vol. 14, Iss. 4, pp. 27-27
Open Access | Times Cited: 17
Structural interactions of phytoconstituent(s) from cinnamon, bay leaf, oregano, and parsley with SARS‐CoV ‐2 nucleocapsid protein: A comparative assessment for development of potential antiviral nutraceuticals
Ishrat Husain, Rumana Ahmad, Sahabjada Siddiqui, et al.
Journal of Food Biochemistry (2022) Vol. 46, Iss. 10
Open Access | Times Cited: 16
In silico identification of novel chemical compounds with antituberculosis activity for the inhibition of InhA and EthR proteins from Mycobacterium tuberculosis
Sajal Kumar Halder, Fatiha Elma
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases (2021) Vol. 24, pp. 100246-100246
Open Access | Times Cited: 20
Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19
Hong Zhou, Wei‐Jian Ni, Wei Huang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top